SQZ Biotechnologies Company (SQZB)
USD 0.03
(1.82%)
USD 0.03
(1.82%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2022 | -64.14 Million USD | -11.09% |
| 2021 | -57.73 Million USD | -43.93% |
| 2020 | -40.11 Million USD | -34.12% |
| 2019 | -29.9 Million USD | -54.67% |
| 2018 | -18.18 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 Q2 | -14.86 Million USD | 2.26% |
| 2023 Q1 | -15.2 Million USD | -163.16% |
| 2023 Q3 | -13.88 Million USD | 6.53% |
| 2022 FY | - USD | -11.09% |
| 2022 Q1 | -18.3 Million USD | -100.73% |
| 2022 Q4 | -5.77 Million USD | 71.47% |
| 2022 Q2 | -19.81 Million USD | -8.27% |
| 2022 Q3 | -20.24 Million USD | -2.18% |
| 2021 Q3 | -19.67 Million USD | 0.0% |
| 2021 FY | - USD | -43.93% |
| 2021 Q4 | -9.11 Million USD | 53.66% |
| 2020 FY | - USD | -34.12% |
| 2019 FY | - USD | -54.67% |
| 2018 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | -71.03 Million USD | 9.706% |
| Nanobac Pharmaceuticals, Incorporated | -5.92 Million USD | -981.835% |
| Evofem Biosciences, Inc. | -17.37 Million USD | -269.263% |
| Santhera Pharmaceuticals Holding AG | 94.03 Million USD | 168.207% |
| Mesoblast Limited | -62.38 Million USD | -2.807% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -4075.713% |
| Genus plc | 73.7 Million USD | 187.03% |
| VioQuest Pharmaceuticals, Inc. | -6.61 Million USD | -870.14% |
| CNBX Pharmaceuticals Inc. | -3.54 Million USD | -1708.318% |
| Marizyme, Inc. | -34.28 Million USD | -87.101% |
| ContraFect Corporation | -64.99 Million USD | 1.32% |
| Nymox Pharmaceutical Corporation | -8.77 Million USD | -631.202% |
| PsyBio Therapeutics Corp. | -4.52 Million USD | -1317.106% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -4475.591% |
| Intellipharmaceutics International Inc. | -2.64 Million USD | -2325.497% |
| AXIM Biotechnologies, Inc. | -2.32 Million USD | -2660.154% |
| MultiCell Technologies, Inc. | -518.04 Thousand USD | -12281.333% |
| Accustem Sciences Inc. | -3.74 Million USD | -1612.062% |
| RVL Pharmaceuticals plc | -48.22 Million USD | -32.998% |
| EV Biologics, Inc. | -1.26 Million USD | -4961.904% |
| Q BioMed Inc. | -617.62 Thousand USD | -10285.054% |
| Emmaus Life Sciences, Inc. | 3.57 Million USD | 1895.661% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -10042.377% |
| Mosaic ImmunoEngineering Inc. | -2.28 Million USD | -2707.674% |
| Biomind Labs Inc. | -1.03 Million USD | -6099.9% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | 9.87 Million USD | 749.398% |
| Oncotelic Therapeutics, Inc. | -7.16 Million USD | -795.665% |
| Skye Bioscience, Inc. | -13.54 Million USD | -373.451% |
| Therapeutic Solutions International, Inc. | -1.48 Million USD | -4212.255% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | -256464.0% |
| Arch Therapeutics, Inc. | -3.88 Million USD | -1551.28% |
| IMV Inc. | -35.52 Million USD | -80.56% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | -304.172% |
| Curative Biotechnology, Inc. | -2.5 Million USD | -2463.628% |
| GB Sciences, Inc. | -1.41 Million USD | -4417.338% |
| Alpha Cognition Inc. | -9.7 Million USD | -560.866% |
| HST Global, Inc. | -5303.00 USD | -1209422.912% |
| CSL Limited | 4.78 Billion USD | 101.339% |
| Halberd Corporation | -74.27 Thousand USD | -86251.459% |
| Enzolytics Inc. | -2.12 Million USD | -2922.626% |
| Resverlogix Corp. | -11.74 Million USD | -446.253% |
| Affymax, Inc. | -14.29 Million USD | -348.695% |
| SYBLEU INC | -141.57 Thousand USD | -45206.595% |
| Nuo Therapeutics, Inc. | -3.06 Million USD | -1994.047% |
| argenx SE | -216.02 Million USD | 70.308% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -55.33 Million USD | -15.906% |
| Enzon Pharmaceuticals, Inc. | 1.21 Million USD | 5370.419% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | -1.49 Million USD | -4179.188% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | 378.84 Thousand USD | 17030.716% |
| AVAX Technologies, Inc. | -6.11 Million USD | -949.317% |
| Zenith Capital Corp. | -8.6 Million USD | -645.306% |
| Genscript Biotech Corporation | -248.71 Million USD | 74.212% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -368082.079% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.44 Million USD | -2521.787% |
| WPD Pharmaceuticals Inc. | -176.02 Thousand USD | -36338.707% |
| American Oriental Bioengineering, Inc. | -39.63 Million USD | -61.822% |
| Provectus Biopharmaceuticals, Inc. | -2.89 Million USD | -2117.627% |
| Adynxx, Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | -1.04 Million USD | -6030.198% |
| GlobeStar Therapeutics Corporation | 6724.00 USD | 954011.362% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -1.74 Million USD | -3565.202% |
| Cotinga Pharmaceuticals Inc. | -1.92 Million USD | -3239.093% |
| BioStem Technologies, Inc. | -7.55 Million USD | -749.14% |
| ONE Bio Corp. | 13.61 Million USD | 571.173% |
| Reve Technologies, Inc. | -181.08 Thousand USD | -35319.796% |
| Burzynski Research Institute, Inc. | - USD | Infinity% |
| Wesana Health Holdings Inc. | -2.05 Million USD | -3018.182% |
| Agentix Corp. | -1.37 Million USD | -4575.832% |
| LadRx Corporation | 412.28 Thousand USD | 15657.518% |
| Cell Source, Inc. | -4.27 Million USD | -1401.243% |
| ProtoKinetix, Incorporated | -367.22 Thousand USD | -17366.594% |
| Regen BioPharma, Inc. | 1.46 Million USD | 4475.37% |
| Regen BioPharma, Inc. | -936.94 Thousand USD | -6745.73% |
| NovAccess Global Inc. | -1.03 Million USD | -6098.414% |
| Endonovo Therapeutics, Inc. | 8.85 Million USD | 824.446% |
| Itoco Inc. | -1.86 Million USD | -3331.844% |
| Rasna Therapeutics, Inc. | -379.62 Thousand USD | -16796.107% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -5647.401% |
| Kadimastem Ltd | -2.62 Million USD | -2344.043% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | -239.15 Thousand USD | -26720.406% |
| CytoDyn Inc. | -18.02 Million USD | -255.766% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.02 Thousand USD | -81061.346% |
| Mobile Lads Corp. | -2.24 Million USD | -2761.957% |
| NanoSphere Health Sciences Inc. | -12.22 Thousand USD | -524399.141% |
| Qrons Inc. | -40.08 Thousand USD | -159928.442% |
| Alseres Pharmaceuticals, Inc. | -485.67 Thousand USD | -13106.487% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | 527.43 Thousand USD | 12260.976% |
| Rebus Holdings, Inc. | -951 Thousand USD | -6644.585% |
| ImmunoCellular Therapeutics, Ltd. | -1.06 Million USD | -5939.585% |
| International Stem Cell Corporation | 202 Thousand USD | 31852.97% |
| Bioxytran, Inc. | -3.82 Million USD | -1579.019% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -121748.404% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.46 Million USD | -2505.312% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -35.86 Million USD | -78.82% |
| Adhera Therapeutics, Inc. | - USD | Infinity% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -45 Thousand USD | -142435.556% |
| Innovation Pharmaceuticals Inc. | -2.73 Million USD | -2242.622% |
| Neutra Corp. | -181.24 Thousand USD | -35288.724% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | -218.176% |
| PureTech Health plc | -11.62 Million USD | -451.656% |
| Coeptis Therapeutics, Inc. | -20.15 Million USD | -218.197% |
| IXICO plc | -707 Thousand USD | -8972.277% |
| IntelGenx Technologies Corp. | -7.68 Million USD | -734.626% |
| Gelesis Holdings, Inc. | -48.34 Million USD | -32.671% |
| CSL Limited | 4.73 Billion USD | 101.355% |
| Cellectis S.A. | -92.63 Million USD | 30.76% |